European Immunization Week (EIW) is marked across the European Region every April. It aims to raise awareness of the importance of immunisation for people’s health and well-being. ECDC supports the European Immunization Week campaign lead by WHO/Europe by providing scientific evidence on immunisation.
A new case of Middle East respiratory syndrome coronavirus (MERS-CoV) has been confirmed by Public Health England (PHE) on the 23 August. Health authorities are identifying close contacts of the patient as a precautionary measure. This is the fifth case of MERS-CoV diagnosed in England, where there have been no cases since 2013.
Since the last update by ECDC in its risk assessment of 11 June 2015, 18 new cases and one death in a previously reported case have been reported by South Korean authorities.
On 23 November WHO Europe published the results from the 5th annual meeting of the European Regional Verification Commission for Measles and Rubella Elimination (RVC).
During the course of European Immunisation Week (EIW), 24 – 30 April 2016, ECDC is putting the spotlight on its resources in support of measles and rubella elimination. These range from disease surveillance and epidemic intelligence to communication tools and guides on awareness raising about the importance of vaccination, as well as the vaccination scheduler tool.
European Immunization Week (EIW) is celebrated across the European Region every April. It aims to raise awareness of the importance of immunization for people’s health and well-being. Activities in 2016 focused on the progress and challenges in the Region’s concerted effort to eliminate measles and rubella.
3 969 cases of measles were reported by 30 EU/EEA countries from 1 January to 31 December 2015, according to ECDC’s latest measles and rubella monitoring report. One measles-related death was reported in a 19 month old child, and six cases were complicated by acute measles encephalitis.